Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2023)
Precision Biosciences' Liabilities from Discontinued Operations was $128,000 in fiscal Q4 2023 (quarter ended Dec 31, 2023), down 92.5% from $1.72 million a year earlier.
Powered by 
Analysis
Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends
- In earlier fiscal years, Liabilities from Discontinued Operations was $1.72 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Precision Biosciences | 166.80 Mn | -182.39 Mn | - |
API Access
Precision Biosciences Liabilities from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-from-discontinued-operations", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();